In this podcast, Drs. Linda Martin (UVA) and Dennis Wigle (Mayo Clinic Rochester, MN) discuss key updates in the treatment of early stage surgically resectable non small cell lung cancer from the 2025 American Society of Clinical Oncology Annual Meeting. Topics include updated survival data from the CheckMate 816 trial of neoadjuvant nivolumab plus chemotherapy, the practice impact of PROSPECT lung accrual, and results from the NeoADAURA trial of neoadjuvant osimertinib. This episode was sponsored by BMS.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Lung nodule localization prior to thoracic surgery
N2 Disease - Are There Any Rules Anymore!
ALINA Trial and Adjuvant Therapy
ESMO Meeting Update & Looking Ahead to 2024
Free AI-powered recaps of GTSC Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.